Australian small-cap healthcare stock Admedus now has a calendar year reporting season, and on the 28th February 2018 it accordingly announced its financial results for the second half of 2017, covering the period 30 June to 31 December 2017. Admedus has… Read More ›
Professor Ian Frazer
Allo Admedus!
In the words of Alice in Wonderland, it all gets “Curioser and Curioser”. Admedus is a fledgling healthcare stock on course to make its mark globally, but the market is unconvinced that this will happen anytime soon. Time and again,… Read More ›